Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Background : Retrospective studies have suggested that hormone replacement therapy may reduce the rate of bone loss in primary biliary cirrhosis, but no controlled data are available. Methods : Forty‐two post‐menopausal women with primary biliary cirrhosis were treated with calcium and vitamin D, either alone (n = 21) or together with transdermal hormone replacement therapy (n = 21). Bone densitometry was performed at baseline and at 1 year, and serum and urinary markers of bone turnover were measured at three‐monthly intervals. Results : At entry, 17 patients (40%) had spinal or femoral osteopenia (T score − 1 to − 2.5) and nine (21%) had osteoporosis (T < − 2.5). In those given hormone replacement therapy, there was a significant decrease in the mean urinary deoxypyridinoline :creatinine ratios at 3 months (7.8 vs. 6.1 n m/m m creatinine for no hormone replacement therapy vs. hormone replacement therapy; P = 0.04) and a 48% reduction in urinary calcium excretion at 1 year (0.66 vs. 0.32 m m/m m creatinine; P = 0.01). Repeat bone densitometry at 1 year revealed a 2.25% increase in the hormone replacement therapy group (P = 0.02), compared with a non‐significant 0.87% decrease in L2–L4 bone mineral density in those not given hormone replacement therapy. Both treatment regimens were well tolerated, with no increase in cholestasis. Conclusions : Compared with calcium and vitamin D alone, supplemental treatment with transdermal hormone replacement therapy for 1 year improved the vertebral bone density and urinary markers of bone turnover in post‐menopausal women with primary biliary cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F. (1991) · Hepatology · doi:10.1002/hep.1840140215 · Cited by 297
Guidelines on the management of osteoporosis associated with chronic liver disease
Collier, J. D., Ninkovic, M., & Compston, J. E. (2002) · Gut · doi:10.1136/gut.50.suppl_1.i1 · Cited by 241
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression
Menon, K. V. N., Angulo, P., Weston, S., Dickson, E. R., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00144-1 · Cited by 180
Research works printed but not linked: 41
- Riggs BL, 1993, The prevention and treatment of osteoporosis, N Engl J Med, 327, 620
- 10.1016/0140-6736(90)91801-G · DOI · Paper page
- 10.1172/JCI115588 · DOI · Paper page
- 10.1016/0140-6736(93)90571-W · DOI
- Crippin JS, 1994, Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment, Am J Gastroenterol, 89, 47
- 10.1002/hep.1840070420 · DOI
- 10.1016/0016-5085(91)90220-F · DOI
- 10.1210/jc.83.2.410 · DOI
- 10.1056/NEJM199611213352107 · DOI · Paper page
- 10.1016/0016-5085(85)90001-0 · DOI
- 10.1016/0016-5085(92)91815-L · DOI
- World Health Organization., 1994, Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report No. 843.
- 10.1111/j.1365-2362.1993.tb00967.x · doi:10.1111/j.1365-2362.1993.tb00967.x
- Power MJ, 1989, Solid‐phase enzymoimmunoassay for osteocalcin in human serum or plasma, with use of a monoclonal antibody, Clin Chem, 35, 2087, 10.1093/clinchem/35.10.2087 · doi:10.1093/clinchem/35.10.2087
- 10.1016/0016-5085(95)90033-0 · DOI
- 10.1002/hep.1840210138 · DOI
- 10.7326/0003-4819-103-6-855 · DOI · Paper page
- 10.1002/hep.1840070127 · DOI · Paper page
- 10.1097/00042737-199903000-00018 · DOI · Paper page
- 10.1016/8756-3282(86)90015-3 · DOI
- 10.1016/S0016-5085(88)80029-5 · DOI
- 10.1210/jcem-69-6-1234 · DOI · Paper page
- 10.1016/S1590-8658(03)00078-1 · DOI
- 10.1007/s002239900545 · DOI
- 10.1016/S1297-319X(02)00364-0 · DOI
- 10.1016/S0168-8278(99)80167-6 · DOI
- 10.1016/S0016-5085(00)70423-9 · DOI
- 10.1053/jhep.2001.22758 · DOI · Paper page
- 10.1007/s001980200092 · DOI
- 10.1002/hep.1840210219 · DOI · Paper page
- 10.1056/NEJM199110243251701 · DOI · Paper page
- 10.1136/gut.15.10.788 · DOI
- 10.1016/0270-9139(94)90098-1 · DOI
- 10.1111/j.1478-3231.1999.tb00034.x · DOI · Paper page
- 10.1111/j.1572-0241.2003.07341.x · doi:10.1111/j.1572-0241.2003.07341.x · Paper page
- 10.1111/j.1471-0528.1997.tb10638.x · DOI
- 10.7326/0003-4819-113-2-95 · DOI · Paper page
- 10.1111/j.1471-0528.1994.tb13618.x · DOI
- 1996, Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI, J Am Med Assoc, 276, 1389, 10.1001/jama.1996.03540170033029 · DOI · Paper page
- 10.1136/bmj.312.7041.1254 · DOI · Paper page
- 10.1097/00042737-199908000-00001 · DOI
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Hormone replacement therapy is effective in post-menopausal female patients [236,237].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
EASL Clinical Practice Guidelines on nutrition in chronic liver disease
Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., Plauth, M., & Parés, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.024 · Cited by 1,130
Hirschfield, G. M., & Heathcote, E. J. (2010) · Evidence‐Based Gastroenterology and Hepatology · doi:10.1002/9781444314403.ch32 · Cited by 261
Bone disorders in chronic liver disease
Collier, J. (2007) · Hepatology · doi:10.1002/hep.21852 · Cited by 238
Metadata
- Authors
- Pereira, S. P., O'Donohue, J., Moniz, C., Phillips, M. G., Abraha, H., Buxton‐Thomas, M., & Williams, R.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2004-02-19
- Volume
- 19
- Issue
- 5
- Pages
- 563-570
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1981342139
- Cited by
- 49
- References
- 5
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial. https://app.cochat.ai/papers/10.1111/j.1365-2036.2004.01890.x
- The paper
- Pereira, S. P., O'Donohue, J., Moniz, C., Phillips, M. G., Abraha, H., Buxton‐Thomas, M., & Williams, R. (2004). Transdermal hormone replacement therapy improves vertebral bone density in primary biliary cirrhosis: results of a 1‐year controlled trial. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2004.01890.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.